Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension

NCT00644475 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Imidapril
DRUG: Candesartan

Sponsor

University of Pavia